Profluent Bio

Profluent Bio

1. Profluent

Hilary Eaton, Ph.D., Chief Business Officer

2. Introducing ProGen3

ProGen3 is a family of generative protein language models, scaled up to 46B parameters, trained on our curated

3. 11th Annual Rare Disease Day Event: Patient Advocate Keynote, Hilary Eaton

4. Ali Madani (Profluent) on the $2.25B Eli Lilly deal and the GPT-1.5 era of biology

5. AI Meets Rett: RSRT funds $1M Collaboration with Profluent to Advance Gene-editing with AI

RSRT has awarded $1 million to

6. How Profluent Bio’s Hilary Eaton Became A Rare Disease Advocate

7. Scriptome Podcast #2 (01/29/2026) - Profluent.Bio's Bet on OpenCRISPR

LINKS MENTIONED:

8. ProGen3 Breakthrough

In this episode, we dive into the ProGen3 AI breakthrough by

9. An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

Today, she's Chief Business Officer at

10. Decoding the Blueprint of Life: How AI is Turning Biology into Programmable Medicine

What if we could move from randomly discovering cures to designing them on demand? In this mind-blowing conversation, ...

11. AI Just Reinvented CRISPR: The Dawn of OpenCRISPR-1

12. This AI Gene Editor Could Split Humanity Into New Species

Sources & Research: Nature (2025) - OpenCRISPR-1 Publication Stanford University Viral Evolution Studies

13. How Is AI Revolutionizing Gene Editing

14. BioML Seminar 4.1 - Jeff Ruffolo on Designing proteins with language models

​Speaker Bio: Jeff Ruffolo is Head of Protein Design at

15. How Does OpenCRISPR Use AI To Augment Gene Therapy Research

Hilary Eaton explains how

Introduction of Profluent Bio

Full Profluent Update
Looking for the latest information on Profluent Bio? We've researched comprehensive data, records, and insights about Profluent Bio.

Important Facts

Information Introducing ProGen3 Guide
Explore the main sources for Profluent Bio.

Developments

Full 11th Annual Rare Disease Day Event: Patient Advocate Keynote, Hilary Eaton Update
Stay updated on Profluent Bio's newest achievements.

AI Meets Rett: RSRT funds $1M Collaboration with Profluent to Advance Gene-editing with AI
AI Meets Rett: RSRT funds $1M Collaboration with Profluent to Advance Gene-editing with AI
How Profluent Bio’s Hilary Eaton Became A Rare Disease Advocate
How Profluent Bio’s Hilary Eaton Became A Rare Disease Advocate
Scriptome Podcast #2 (01/29/2026) - Profluent.Bio's Bet on OpenCRISPR
Scriptome Podcast #2 (01/29/2026) - Profluent.Bio's Bet on OpenCRISPR
ProGen3 Breakthrough
ProGen3 Breakthrough
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
Decoding the Blueprint of Life: How AI is Turning Biology into Programmable Medicine
Decoding the Blueprint of Life: How AI is Turning Biology into Programmable Medicine
AI Just Reinvented CRISPR: The Dawn of OpenCRISPR-1
AI Just Reinvented CRISPR: The Dawn of OpenCRISPR-1
This AI Gene Editor Could Split Humanity Into New Species
This AI Gene Editor Could Split Humanity Into New Species
How Is AI Revolutionizing Gene Editing
How Is AI Revolutionizing Gene Editing
BioML Seminar 4.1 - Jeff Ruffolo on Designing proteins with language models
BioML Seminar 4.1 - Jeff Ruffolo on Designing proteins with language models
How Does OpenCRISPR Use AI To Augment Gene Therapy Research
How Does OpenCRISPR Use AI To Augment Gene Therapy Research

Detailed Analysis

Data is compiled from public records and verified media reports.

Last Updated: August 11, 2026

Final Thoughts

Details Ali Madani (Profluent) on the $2.25B Eli Lilly deal and the GPT-1.5 era of biology Update
For 2026, Profluent Bio remains one of the most talked-about information profiles. Check back for the latest updates.

Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.

Video Terkait

Kategori General
Advertisement